<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Through a systematic search in Pubmed for literature, on links between calcium <z:hpo ids='HP_0004395'>malnutrition</z:hpo> and risk of <z:hpo ids='HP_0011010'>chronic</z:hpo> diseases, we found the highest degree of evidence for <z:hpo ids='HP_0000939'>osteoporosis</z:hpo>, colorectal and <z:hpo ids='HP_0003002'>breast cancer</z:hpo>, as well as for <z:hpo ids='HP_0000822'>hypertension</z:hpo>, as the only major <z:e sem="disease" ids="C0850624" disease_type="Disease or Syndrome" abbrv="">cardiovascular risk factor</z:e> </plain></SENT>
<SENT sid="1" pm="."><plain>Low calcium intake apparently has some impact also on cardiovascular events and disease outcome </plain></SENT>
<SENT sid="2" pm="."><plain>Calcium <z:hpo ids='HP_0004395'>malnutrition</z:hpo> can causally be related to low activity of the extracellular calcium-sensing receptor (CaSR) </plain></SENT>
<SENT sid="3" pm="."><plain>This member of the family of 7-TM G-protein coupled receptors allows extracellular <z:chebi fb="0" ids="29108">Ca2+</z:chebi> to function as a "first messenger" for various intracellular signaling cascades </plain></SENT>
<SENT sid="4" pm="."><plain>Evidence demonstrates that <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/CaSR signaling in functional linkage with <z:chebi fb="27" ids="27300">vitamin D</z:chebi> receptor (VDR)-activated pathways (i) promotes osteoblast differentiation and formation of mineralized bone; (ii) targets downstream effectors of the canonical and non-canonical Wnt pathway to inhibit proliferation and induce differentiation of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cells; (iii) evokes <z:chebi fb="0" ids="29108">Ca2+</z:chebi> influx into <z:hpo ids='HP_0003002'>breast cancer</z:hpo> cells, thereby activating pro-apoptotic intracellular signaling </plain></SENT>
<SENT sid="5" pm="."><plain>Furthermore, <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/CaSR signaling opens <z:chebi fb="0" ids="29108">Ca2+</z:chebi>-sensitive K+ conductance channels in vascular endothelial cells, and also participates in IP(3)-dependent regulation of cytoplasmic <z:chebi fb="0" ids="29108">Ca2+</z:chebi>, the key intermediate of cardiomyocyte functions </plain></SENT>
<SENT sid="6" pm="."><plain>Consequently, impairment of <z:chebi fb="0" ids="29108">Ca2+</z:chebi>/CaSR signaling may contribute to inadequate bone formation, <z:e sem="disease" ids="C0178874" disease_type="Neoplastic Process" abbrv="">tumor progression</z:e>, <z:hpo ids='HP_0000822'>hypertension</z:hpo>, <z:hpo ids='HP_0004934'>vascular calcification</z:hpo> and, probably, <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> </plain></SENT>
</text></document>